Botanix Pharmaceuticals (ASX:BOT) Long-Term Debt : A$0.00 Mil (As of Jun. 2024)

View and export this data going back to 1985. Start your Free Trial

What is Botanix Pharmaceuticals Long-Term Debt?

Botanix Pharmaceuticals's Long-Term Debt for the quarter that ended in Jun. 2024 was A$0.00 Mil.

Botanix Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Botanix Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Long-Term Debt Chart

Botanix Pharmaceuticals Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Long-Term Debt

Get a 7-Day Free Trial

Botanix Pharmaceuticals Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Botanix Pharmaceuticals (ASX:BOT) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Botanix Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

BXPHF:USA

Address

41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals Headlines

No Headlines